Medications known as PARP inhibitors have emerged as a promising therapy for several forms of cancer fueled by a defect in the cells’ DNA repair machinery. Yet many people with cancers caused by the defect, known as HR deficiency, who stand to benefit from PARP inhibitors remain unidentified because standard genetic panels used in the… Read More »
Although the majority of patients who have blood cancers are older adults, they make up only a small percentage of participants in the clinical trials that lead to new therapies. That’s because the standard research methods used in oncology (cancer medicine) are not ideal for identifying certain vulnerabilities linked to aging, such as having multiple… Read More »
Print this page THURSDAY, Jan. 10, 2019 — A large, new analysis helps confirm that eating lots of grains, vegetables and fruit lowers your risk of dying early from cancer or heart disease. When compared with those who consume very little fiber, people at the high end of the fiber-eating spectrum saw their risk for… Read More »
Childhood cancers make up less than 1% of all cancers diagnosed each year. About 10,590 children in the United States under the age of 15 will be diagnosed with cancer in 2018. Childhood cancer rates have been rising slightly for the past few decades. Because of major treatment advances in recent decades, more than 80%… Read More »
Through the past 20 years of clinical trials with cancer patient care experience, I summed up a few unexpected anticancer habits. Do not wear high heels. Inflammation is the body’s healing process, but long-term inflammation may lead to heart disease, autoimmune diseases, diabetes and increased risk of cancer. Wear some uncomfortable and inappropriate shoes can… Read More »